Literature DB >> 32301874

KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.

Steven J Chadban1, Curie Ahn2, David A Axelrod3, Bethany J Foster4, Bertram L Kasiske5, Vijah Kher6, Deepali Kumar7, Rainer Oberbauer8, Julio Pascual9, Helen L Pilmore10, James R Rodrigue11, Dorry L Segev12, Neil S Sheerin13, Kathryn J Tinckam7, Germaine Wong14, Gregory A Knoll15.   

Abstract

The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual's suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate's profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.

Entities:  

Mesh:

Year:  2020        PMID: 32301874     DOI: 10.1097/TP.0000000000003136

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  57 in total

Review 1.  An ethical analysis of obesity as a contraindication of pediatric kidney transplant candidacy.

Authors:  Emily R Berkman; Kelsey L Richardson; Jonna D Clark; André A S Dick; Mithya Lewis-Newby; Douglas S Diekema; Aaron G Wightman
Journal:  Pediatr Nephrol       Date:  2022-04-29       Impact factor: 3.714

2.  Clinical practice guideline exercise and lifestyle in chronic kidney disease.

Authors:  Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton
Journal:  BMC Nephrol       Date:  2022-02-22       Impact factor: 2.388

3.  The prognostic value of pre-operative coronary evaluation in kidney transplanted patients.

Authors:  Tali Steinmetz; Leor Perl; Benaya Rozen Zvi; Mohamad Atamna; Ran Kornowski; Arthur Shiyovich; Ashraf Hamdan; Eviatar Nesher; Ruth Rahamimov; Tuvia Ben Gal; Keren Skalsky
Journal:  Front Cardiovasc Med       Date:  2022-08-05

4.  Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom.

Authors:  Lucy A Plumb; Manish D Sinha; Anna Casula; Carol D Inward; Stephen D Marks; Fergus J Caskey; Yoav Ben-Shlomo
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-19       Impact factor: 8.237

5.  End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study.

Authors:  Thabang T Molaoa; Feziwe B Bisiwe; Kwazi Cz Ndlovu
Journal:  BMC Nephrol       Date:  2021-05-11       Impact factor: 2.388

6.  A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.

Authors:  Ibrahim Ali; Rosemary L Donne; Philip A Kalra
Journal:  BMC Nephrol       Date:  2021-05-24       Impact factor: 2.388

7.  Malignancies after pediatric solid organ transplantation.

Authors:  Cal Robinson; Rahul Chanchlani; Abhijat Kitchlu
Journal:  Pediatr Nephrol       Date:  2020-10-15       Impact factor: 3.714

8.  Immunosuppression Considerations for Older Kidney Transplant Recipients.

Authors:  Wisit Cheungpasitporn; Krista L Lentine; Jane C Tan; Matthew Kaufmann; Yasar Caliskan; Suphamai Bunnapradist; Ngan N Lam; Mark Schnitzler; David A Axelrod
Journal:  Curr Transplant Rep       Date:  2021-04-06

9.  Kidney re-transplantation after living donor graft nephrectomy due to de novo chromophobe renal cell carcinoma: A case report.

Authors:  Hui Wang; Wen-Li Song; Wen-Juan Cai; Gang Feng; Ying-Xin Fu
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

10.  Impacts of Interaction of Mental Condition and Quality of Life between Donors and Recipients at Decision-Making of Preemptive and Post-Dialysis Living-Donor Kidney Transplantation.

Authors:  Toshiki Hasegawa; Kouhei Nishikawa; Yuko Tamura; Tomoka Oka; Aiko Urawa; Saori Watanabe; Shugo Mizuno; Motohiro Okada
Journal:  J Pers Med       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.